Latest news
Jack Shuang Hou: What an AstraZeneca-BMS Merger Means for Global Oncology - OncodailyOncodaily · Wed, 05 Aug 2026 09:45:50 GMTAstraZeneca (AZN) Receives a Buy from UBS - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 09:06:00 GMTPost-Hoc Live: Who wants an AstraZeneca-Bristol Myers megadeal? - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 10:00:00 GMTAstraZeneca shares slump after $400bn BMS merger rumours - Pharmaceutical TechnologyPharmaceutical Technology · Tue, 04 Aug 2026 08:57:27 GMT‘Huh?’ Markets React to AstraZeneca’s Megadeal Talks With Bristol Myers - The Daily UpsideThe Daily Upside · Tue, 04 Aug 2026 04:01:00 GMTAstraZeneca investors balk at prospect of $400 billion Bristol Myers pharma deal - ReutersReuters · Mon, 03 Aug 2026 18:43:06 GMTBristol Myers Squibb Stock Falls on Report of $400 Billion Merger Talks With AstraZeneca - Barron'sBarron's · Mon, 03 Aug 2026 18:16:00 GMTAn AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled. - BioPharma DiveBioPharma Dive · Mon, 03 Aug 2026 16:29:12 GMT